Pharmacological effects of Chinese medicine modulating NLRP3 inflammasomes in fatty liver treatment

Inflammation is a key contributing factor in the pathogenesis of fatty liver diseases (FLD), such as nonalcoholic fatty liver disease (NAFLD) and alcohol-associated liver diseases (ALDs). The NLRP3 inflammasome is widely present in the hepatic parenchymal and non-parenchymal cells, which are assembl...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Tingting Liu, Guang Xu, Longxin Liang, Xiaohe Xiao, Yanling Zhao, Zhaofang Bai
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2022-09-01
coleção:	Frontiers in Pharmacology
Assuntos:	Chinese medicine NLRP3 inflammasome inhibitor NAFLD ALD liver fibrosis
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fphar.2022.967594/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!